Hsinchu, Taiwan

Jyh-Hsiung Liao


 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Hsinchu, TW (2010 - 2016)
  • Kaohsiung, TW (2017)
  • Tainan, TW (2018)

Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Jyh-Hsiung Liao

Introduction

Jyh-Hsiung Liao is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. With a total of five patents to his name, Liao's work has had a considerable impact on the industry.

Latest Patents

Liao's latest patents include a process for preparing ixazomib citrate and intermediates therefor. This process involves reacting a compound with citric acid to form ixazomib citrate. Another notable patent is for preparing SGLT2 inhibitors and intermediates thereof, which includes processes for creating drugs such as dapagliflozin and empagliflozin.

Career Highlights

Throughout his career, Jyh-Hsiung Liao has worked with reputable organizations, including Scinopharm Taiwan, Ltd. and the National Health Research Institutes. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical field.

Collaborations

Liao has collaborated with several talented individuals in his field, including Tsung-Yu Hsiao and Julian Paul Henschke. These collaborations have fostered innovation and have been instrumental in advancing their shared research goals.

Conclusion

Jyh-Hsiung Liao's contributions to pharmaceutical innovations through his patents and collaborations highlight his importance in the field. His work continues to influence the development of new medications and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…